[1]
Lee SL. Radioactive iodine therapy. Current opinion in endocrinology, diabetes, and obesity. 2012 Oct:19(5):420-8. doi: 10.1097/MED.0b013e328357fa0c. Epub
[PubMed PMID: 22914564]
Level 3 (low-level) evidence
[2]
Fard-Esfahani A, Emami-Ardekani A, Fallahi B, Fard-Esfahani P, Beiki D, Hassanzadeh-Rad A, Eftekhari M. Adverse effects of radioactive iodine-131 treatment for differentiated thyroid carcinoma. Nuclear medicine communications. 2014 Aug:35(8):808-17. doi: 10.1097/MNM.0000000000000132. Epub
[PubMed PMID: 24751702]
[3]
Sawin CT,Becker DV, Radioiodine and the treatment of hyperthyroidism: the early history. Thyroid : official journal of the American Thyroid Association. 1997 Apr;
[PubMed PMID: 9133679]
[4]
Wyszomirska A. Iodine-131 for therapy of thyroid diseases. Physical and biological basis. Nuclear medicine review. Central & Eastern Europe. 2012 Aug 28:15(2):120-3
[PubMed PMID: 22936505]
[5]
Limaiem F, Rehman A, Anastasopoulou C, Mazzoni T. Papillary Thyroid Carcinoma. StatPearls. 2023 Jan:():
[PubMed PMID: 30725628]
[8]
Mumtaz M, Lin LS, Hui KC, Mohd Khir AS. Radioiodine I-131 for the therapy of graves' disease. The Malaysian journal of medical sciences : MJMS. 2009 Jan:16(1):25-33
[PubMed PMID: 22589645]
[9]
Ahad F,Ganie SA, Iodine, Iodine metabolism and Iodine deficiency disorders revisited. Indian journal of endocrinology and metabolism. 2010 Jan;
[PubMed PMID: 21448409]
[11]
Marcocci C, Bartalena L, Tanda ML, Manetti L, Dell'Unto E, Mazzi B, Rocchi R, Barbesino G, Pinchera A. Graves' ophthalmopathy and 131I therapy. The quarterly journal of nuclear medicine : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR). 1999 Dec:43(4):307-12
[PubMed PMID: 10731781]
[12]
Reiners C,Schneider R, Potassium iodide (KI) to block the thyroid from exposure to I-131: current questions and answers to be discussed. Radiation and environmental biophysics. 2013 May;
[PubMed PMID: 23475155]
[13]
Becker DV, Zanzonico P. Potassium iodide for thyroid blockade in a reactor accident: administrative policies that govern its use. Thyroid : official journal of the American Thyroid Association. 1997 Apr:7(2):193-7
[PubMed PMID: 9133683]
[14]
Bhat M, Mozzor M, Chugh S, Buddharaju V, Schwarcz M, Valiquette G. Dosing of radioactive iodine in end-stage renal disease patient with thyroid cancer. Endocrinology, diabetes & metabolism case reports. 2017:2017():. doi: 10.1530/EDM-17-0111. Epub 2017 Nov 10
[PubMed PMID: 29158901]